Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Micky D Tortorella

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Arthritis and Rheumatism|December 16, 2003
The usual suspects: verdict not guilty?Micky D Tortorella, Anne-Marie Malfait
Clinical and Experimental Rheumatology|October 18, 2019
The "elusive DMOAD": Aggrecanase inhibition from laboratory to clinicAnne-Marie Malfait, Micky D Tortorella
Mini Reviews in Medicinal Chemistry|May 10, 2016
Desirable Properties for 3rd Generation Cyclooxygenase-2 InhibitorsMicky D Tortorella, Yanmei Zhang, John Talley
Current Rheumatology Reports|August 10, 2013
Genetically Engineered Mouse Models Reveal the Importance of Proteases as Osteoarthritis Drug TargetsRachel E Miller, Yongzhi Lu, Micky D Tortorella, et al.
Cellular and Molecular Neurobiology|February 14, 2026
Entorhinal Cholecystokinin in Alzheimer's Disease: Its Earliest Vulnerability and Rescue Effects Across Different Disease Stages in a Mouse ModelYixuan Sui, Nan Zhang, Xi Chen, et al.
The Journal of Biological Chemistry|April 17, 2002
Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilageAnne-Marie Malfait, Rui-Qin Liu, Kosei Ijiri, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 24, 2002
Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4)Micky D Tortorella, Rui-Qin Liu, Timothy Burn, et al.
Current Pharmaceutical Design|July 16, 2009
A review of the ADAMTS family, pharmaceutical targets of the futureMicky D Tortorella, Fransiska Malfait, Ruteja A Barve, et al.
Archives of Biochemistry and Biophysics|May 8, 2010
Transport and equilibrium uptake of a peptide inhibitor of PACE4 into articular cartilage is dominated by electrostatic interactionsSangwon Byun, Micky D Tortorella, Anne-Marie Malfait, et al.
Arthritis and Rheumatism|September 2, 2006
Identification of fibronectin neoepitopes present in human osteoarthritic cartilageMarc D Zack, Elizabeth C Arner, Charles P Anglin, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Arthritis and Rheumatism|December 16, 2003
The usual suspects: verdict not guilty?Micky D Tortorella, Anne-Marie Malfait
Clinical and Experimental Rheumatology|October 18, 2019
The "elusive DMOAD": Aggrecanase inhibition from laboratory to clinicAnne-Marie Malfait, Micky D Tortorella
Mini Reviews in Medicinal Chemistry|May 10, 2016
Desirable Properties for 3rd Generation Cyclooxygenase-2 InhibitorsMicky D Tortorella, Yanmei Zhang, John Talley
Current Rheumatology Reports|August 10, 2013
Genetically Engineered Mouse Models Reveal the Importance of Proteases as Osteoarthritis Drug TargetsRachel E Miller, Yongzhi Lu, Micky D Tortorella, et al.
Cellular and Molecular Neurobiology|February 14, 2026
Entorhinal Cholecystokinin in Alzheimer's Disease: Its Earliest Vulnerability and Rescue Effects Across Different Disease Stages in a Mouse ModelYixuan Sui, Nan Zhang, Xi Chen, et al.
The Journal of Biological Chemistry|April 17, 2002
Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilageAnne-Marie Malfait, Rui-Qin Liu, Kosei Ijiri, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 24, 2002
Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4)Micky D Tortorella, Rui-Qin Liu, Timothy Burn, et al.
Current Pharmaceutical Design|July 16, 2009
A review of the ADAMTS family, pharmaceutical targets of the futureMicky D Tortorella, Fransiska Malfait, Ruteja A Barve, et al.
Archives of Biochemistry and Biophysics|May 8, 2010
Transport and equilibrium uptake of a peptide inhibitor of PACE4 into articular cartilage is dominated by electrostatic interactionsSangwon Byun, Micky D Tortorella, Anne-Marie Malfait, et al.
Arthritis and Rheumatism|September 2, 2006
Identification of fibronectin neoepitopes present in human osteoarthritic cartilageMarc D Zack, Elizabeth C Arner, Charles P Anglin, et al.
Pageof 6